NCT00094965View on ClinicalTrials.gov

Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function

PHASE2CompletedINTERVENTIONAL

Enrollment

43

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Gastrointestinal Cancer

Interventions

DRUG

Oxaliplatin (SR96669)

oxaliplatin in combination with FOLFOX4

Trial Locations (1)

37232-6307

Vanderbilt-Ingram Cancer Center, Nashville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY